📰 Amy Wolf News
Page 3 - Amy Wolf News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amy Wolf. Real-time updates on events, politics, business and more.
July 21, 2023
Positive opinion from Committee for Medicinal Products for Human Use based on Bylvay Phase III ASSERT clinical-trial data in Alagille syndrome Negative opinion from Committee for Orphan Medicinal...
July 19, 2023
European Commission determines not to grant marketing authorization approval for palovarotene for fibrodysplasia ossificans progressiva Decision follows negative opinion by the Committee for Medicinal...
July 19, 2023
European Commission determines not to grant marketing authorization approval for palovarotene for fibrodysplasia ossificans progressiva (FOP)Decision...
July 10, 2023
It seems unlikely that the people of the borough generate any more trash than people in other towns. What's different is how much more of that trash ends up on the street here.
June 30, 2023
Trial met primary endpoint with a statistically significant higher percentage of patients achieving a clinically meaningful cholestasis response compared to placebo Elafibranor was well tolerated with a safety profile consistent with previous studies Resu...
June 30, 2023
Trial met primary endpoint with a statistically significant higher percentage of patients achieving a clinically meaningful cholestasis response compared to placeboElafibranor was well tolerated with a safety profile
June 29, 2023
Advisory committee voted 10 for and 4 against that evidence from the Phase III MOVE study show palovarotene is an effective treatment in patients with the...
June 13, 2023
Approval heralds the second rare cholestatic liver disease indication for Bylvay in the U.S. after progressive familial intrahepatic cholestasis related pruritus in 2021 Immediate U.S. commercial... | June 13, 2023
June 12, 2023
Seven abstracts to be presented demonstrating treatment effects of Bylvay® in two cholestatic liver diseases, progressive familial intrahepatic cholestasis and Alagille syndrome Data to be... | June 12, 2023
June 1, 2023
01.06.2023 - REGULATED INFORMATION Ipsen initiates a share buy-back programto cover its free employee share-allocation plan Paris (France), 1 June 2023 - Ipsen (Euronext: IPN; ADR: IPSEY) has appointed an investment-services provider to purchase an aggregate ...